Daily Stock List
BioDrain Medical, Inc. (BIOR)
OTCPicks and The Green Baron reported previously on BioDrain Medical, Inc. (BIOR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid disposal system. This system virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. The Company is the producer of the FDA approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal that reduces the risk of exposure to hazardous waste. BioDrain Medical lists on the OTC Market's OTCQB. The Company has their corporate headquarters in Eagan, Minnesota.
BioDrain Medical's STREAMWAY® System is eco-friendly and it fully automates the collection, measurement and disposal of surgical fluids. The design of the system is to result in reducing overhead costs to hospitals and surgical centers, improving Occupational State and Health Association (OSHA) and other regulatory compliance agencies' safety concerns, and streamlining the efficiency of the operating room, making surgeries more profitable. Independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country are currently representing BioDrain products.
Concerning the STREAMWAY® System, operative fluid is suctioned directly from the surgical field into the system. This system automatically measures and records volume before it disposes of the fluid directly into a facility's existing plumbing system. Cleaning the STREAMWAY System is user-friendly. One detaches the procedure filter, connects the Company's proprietary cleaning solution, and activates the clean cycle on the touch screen.
On March 5, 2013, BioDrain Medical announced that the Company has completed additional trial installations and sales over the last sixty days of their STREAMWAY® Systems into hospitals and surgical centers in different states. These include New York, Michigan, Minnesota and Pennsylvania. These additional installations and sales included new as well as repeat customers. Previous trial installations of their STREAMWAY® System have resulted in a 100 percent success rate in conversions from a trial installation to a subsequent sale of the system.
BioDrain Medical, Inc. (BIOR), closed Friday's session at $0.115, down 4.56%, on 87,850 volume with 9 trades. The stock's 52-week low/high is $0.0301/$0.14.
CGrowth Capital, Inc. (CGRA)
Stock Twiter, OTPicks, Penny Champions, PennyStocks24, Penny Dreamers, Penny Trackers, InsideBulls, Pennystocktweeters.com, Center Stage Stocks, OtcWizard, and AimHighProfits reported on CGrowth Capital, Inc. (CGRA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Pink Current Information, CGrowth Capital, Inc. serves as a holding company for businesses and assets focused on all aspects of mining. They provide a variety of services and capital resources designed to build value from the mining industry in the western U.S. The Company, through their holdings, affiliates, and partners provides capital, diverse services and processing applications for landowners specific to exploration, mining and metal processing in this region. CGrowth Capital has their headquarters in Silverdale, Washington.
The Company focuses on acquiring or claiming land assets that contain valuable minerals. They subsequently provide management support and the logistical services required for the successful execution of metal ore mining. CGrowth Capital will build value through proving the reserves, then providing ore processing via the Company's joint venture partners and future processing plant(s). The design of CGrowth Capital's services and solutions are to assist landowners with monetizing undervalued assets through bringing commodities such as gold and silver to market.
Earlier this month, CGrowth Capital announced the execution of a Letter of Intent (LOI) with Kirida Resources, Inc. of British Columbia. The agreement outlines the development of Kirida's Cameroon Gold and Diamond permit in West Africa. CGrowth Capital expects to move quickly to a definitive agreement.
CGrowth Capital has performed a review of the Kirida site assessment. It includes an in-depth geological study, field surveys, soil analysis, and sample campaign. From this exploration campaign, the area has been divided into two key regions. The Northern Bindiba region has 19 known Au (gold) occurrences and one diamond occurrence. The Central Kette region has 12 known Au and four diamond occurrences. These targets contain both alluvial and primary rock gold and diamond deposits.
Last week, CGrowth Capital announced that they initiated a significant milestone in the execution of their business plan by signing a Purchasing and Sale Agreement for the Deer Trail Mine in Eastern Washington. The 40-acre fee simple parcel contains three historically active mines and is grandfathered as an active mining site.
The Deer Trail Mine is the location of CGrowth Capital's originally announced joint venture agreement to process 170,000 tons of head ore material. The transaction once complete will take the place of the joint venture agreement; it gives the Company access to an estimated 200,000 tons of surface material.
CGrowth Capital, Inc. (CGRA), closed Friday's trading session at $0.089, up 27.14%, on 21,600 volume with 5 trades. The stock's 52-week low/high is $0.01/$0.25.
Castillian Resources Corp. (CTIIF)
Today we are reporting on Castillian Resources Corp. (CTIIF), here at the QualityStocks Daily Newsletter.
Castillian Resources Corp. is a mineral exploration company with corporate headquarters in Toronto, Ontario. The Company has gold and base metal properties in Canada and South America. Castillian's flagship property is the Hope Brook Gold Project located in southwestern Newfoundland. Castillian Resources lists on the OTC Markets' OTCQX International.
At the Company's flagship Hope Brook Gold Project, Castillian is carrying out a 25,000-meter diamond drill program. The Hope Brook Gold Project has 2.4 million tonnes at 1.48 g Au/t for 590,000 ounces of National Instrument (NI) 43-101 compliant indicated mineral resources and 8.2 million tonnes at 2.07 g Au/t for 548,000 ounces of inferred mineral resources. At the Hope Brook Gold Project, the deposit is open along strike and at depth with several target areas already defined. The Company believes there is excellent potential to expand the resource.
In January 2013, Castillian Resources announced that they completed 5,951 meters of reconnaissance diamond drilling in 21 holes at their Hope Brook Gold Project. Highlights include a major new near surface target zone within the Connector Zone and above the 240 Zone that extends along strike for approximately 800m to a depth of more than 300m.
Highlights also include Hole HB12-100: 1.51 grams gold per tonne (g Au/t) over 14.0m, including 2.03 g Au/t over 8.0m and 1.07 g Au/t over 18.1m core length, including 1.68 g Au/t over 5.5m core length within a 57 m wide silicified zone in the Connector Target. Additionally, highlights include Hole HB12-101: 1.04 g Au/t over 8.5m core length, 1.44 g Au/t over 2.9m core length and 1.35 g Au/t over 5.6m core length within an overall 75m wide silicified zone 100m northeast of hole HB12-100.
Castillian Resources has outlined an extensive new Gold-in-Soil anomaly trend on their Canadian Creek Gold Project in the Yukon, adjacent to Kaminak's Sugar Gold-in-Soil trend. Drilling by previous operators has confirmed major gold mineralization including 0.72 g Au/t over 55.3m. The significant new gold-in-soil anomaly, the Canadian Creek trend, is 7.5 kilometers long by 2 kilometers wide. A major structural zone, greater than 10 kilometers along strike, is sub-parallel to the gold-in-soil trend.
Last month, Castillian Resources announced that Ryan Gold completed their obligations concerning the acquisition of a 10 percent interest in Castillian's Hope Brook Gold property. This was through incurring aggregate exploration expenditures on the Property of $2,000,000 by December 31, 2012. Castillian Resources and Ryan Gold will form a joint venture. With it, Ryan Gold will have a carried 10 percent interest until December 31, 2013, following which each company will contribute to more expenditure on the Property in proportion to their respective joint venture interests.
Castillian Resources Corp. (CTIIF), closed Friday's trading session at $0.0654, down 6.44%, on 165,400 volume with 14 trades. The stock's 52-week low/high is $0.016/$0.079.
Epazz, Inc. (EPAZ)
The Stock Brainiac, Stock Edge, Your Stock Alert, Small Caps, Blaque Capital Stocks, Xtreme Stock Picks, PennyStock MarketBulls, Email Stock Picks, JackpotStock Picks, RagingStockBull, PennyStock PayCheck, and Day Trade Alert reported earlier on Epazz, Inc. (EPAZ), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Based in Chicago, Illinois, Epazz, Inc. is a leading provider of cloud based business software solutions. The Company's specialty is providing customized cloud applications to the corporate world, higher education institutions and the public sector. Shaun Passley founded Epazz in February 1999. Shaun Passley is Epazz's Chairman and Chief Executive Officer. The Company has created software to enhance the ways institutions and corporations do business. Epazz lists on the OTC Markets' OTCQB.
Epazz BoxesOS™ v3.0 is a complete business web-based software package for small to mid-size businesses, Fortune 500 enterprises, government agencies, and higher education institutions. BoxesOS provides several of the web-based applications organizations would have to buy separately.
The Company's other products are AgentPower™ and AutoHire™. AgentPower™ software provides information and tools for call centers to help enhance their workforce management. AutoHire™ software is an applicant tracking system. It is a tool to power career centers, post job ads to sites and job boards, and to collect resumes online.
Epazz announced yesterday that in the most recent quarter, the Company reported a 50 percent and 32.5 percent increase in revenues respectively for the nine-month period ending September30, 2012. The Company reported revenue of $856,248 compared to revenue of $646,023 for the same period in 2011. Moreover, their Asset value grew by 38 perccent to $1,425,248 during the nine-month period ending on September 30, 2012.
In addition, the Company announced a 300 percent increase in their client base in 2012. Epazz expects those numbers to continue to climb; with pending acquisitions, they expect revenues to double in 2013. Furthermore, the Company reported that Project Flex has passed all beta tests. It is at the next stage, which will lead to a spin-off of the new Company with a dividend being paid to shareholders. Project Flex is a patent pending new technology that the Company believes will change the way cooling technology is used.
Epazz, Inc. (EPAZ), closed Friday's trading session at $0.0025, up 4.17%, on 30,307,213 volume with 171 trades. The stock's 52-week low/high is $0.001/$0.045.
Aquila Resources, Inc. (AQARF)
We are highlighting Aquila Resources, Inc. (AQARF) today, here at the QualityStocks Daily Newsletter.
Listed on the OTC Pink Current Information, Aquila Resources, Inc. engages in the mineral exploration business. They are focusing on the discovery and development of high-grade base and precious metal projects in highly prospective regions of North America. The Company is concentrating on mineral and surface rights at the Back Forty Project located in Michigan's Upper Peninsula. In addition, Aquila is involved in base metals and gold exploration throughout the United States. More specifically this is in the Great Lakes Region. Aquila Resources has offices in Toronto, Ontario, and Menominee, Michigan. The Company also has an exploration office in Medford, Wisconsin.
Aquila Resources has a 49 percent interest in the aforementioned gold and zinc Back Forty Project. HudBay Minerals, Inc. (TSX: HBM; NYSE: HBM) holds a 51 percent interest. The Back Forty project is an advanced-staged exploration project delineating a zinc and gold rich volcanogenic massive sulfide (VMS) deposit located within the Penokean Volcanic Belt. Aquila Resources also has 100 percent control of six base and precious metal projects.
On February 4, 2013, Aquila Resources provided an updated mineral resource estimate for the Back Forty Project. The updated mineral resource estimate includes data from an additional 78 drill holes.
The open pit measured and indicated resource is 9.65 million tonnes. It has improved metal grades over the prior mineral resource estimate, prepared in 2010.
The estimate also defined 5.49 million measured and indicated tonnes and 2.18 million inferred tonnes of underground resource not evaluated in the preliminary economic assessment (PEA) completed in April 2012. The mine plan in the PEA considered that 7.54 million tonnes of the measured and indicated resource would be mined, after applying dilution and recovery allowances.
This week, Aquila Resources announced that they retained Mr. Barry Hildred on a consulting basis as Chief Executive Officer (CEO) to provide Corporate Development, Financial Advisory, as well as overall management services. As CEO, Mr. Hildred will report directly to the Board of Directors. Mr. Thomas Quigley, Aquila Resources' current President and CEO, will retain the title of President. Mr. Quigley will lead the Company's technical efforts in the United States.
Mr. Hildred is an experienced executive and successful entrepreneur with diverse business leadership experience. Mr. Hildred is a principal at Level 2 Advisors. Level 2 sources investment opportunities and provides advisory services to small and medium enterprises.
Aquila Resources, Inc. (AQARF), closed today at $0.1399, up 15.62%, on 12,975 volume with 4 trades. The average volume for the last 60 days is 19,135 and the stock's 52-week low/high is $0.108/$0.5056.
Lot78, Inc. (LOTE)
Penny Dreamers, PennyStocks24, Stock Twiter, PennyStockSpy, AimHighProfits, SUPERSTOCKPLAYS, PennyStockClub, The Stock Scout, Penny Stock Pros, Penny Stock Circle, 1-2-3 Stock Alerts, StockMarketQuote.us, and Penny Stock Rumble reported this month on Lot78, Inc. (LOTE), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Lot78, Inc. is a trend-setting leader in the design, marketing, distribution and sale of urban apparel. The Company retails under the brand name "Lot78" on six continents (North America, Europe, Asia, Australia, Africa and South America). Established in 2008 by London based designer Ollie Amhurst, Lot78, in essence, is a contemporary ready to wear luxury-clothing brand for men and women. Lot78 has their headquarters in London, England.
US Weekly, Elle Magazine, Financial Times, Harrods Magazine, The London Evening Standard, and Grazia Magazine have featured Lot78 as an emerging worldwide brand. The Company's current collection is a full men and women's contemporary ready-to-wear line. It includes leather jackets, coats, knitwear, jeans, chinos, t-shirts, sweats, accessories, as well as home ware.
Lot78 joins the individual styling and attitude of London street wear married with world-renowned tailoring and materials from Northern Italy. The Company's collection is available in the world's most prestigious luxury retail outlets and through the lot78 online store.
Earlier this month, Lot78 announced that they extended and increased their United Kingdom distribution with Harrods. Harrods is an up-scale department store located in Brompton Road in Knightsbridge, in the Royal Borough of Kensington and Chelsea, London. The Harrods brand also applies to other enterprises undertaken by the Harrods group of companies.
This week, Lot78 announced that they extended their worldwide distribution agreement with online retail group NET-A-PORTER. The NET-A-PORTER Group is the world's premier online luxury fashion retailer.
Co-Founder of NET-A-PORTER, Ms. Holli Roger stated, "Lot78 will prove to be a wardrobe of timeless classics that appeal to any age. The brand also has the incredible benefit of appealing to those with a predilection towards trends in that its simplicity and fantastic fit lends itself to mixing well with any wardrobe choice regardless of trend. Lot78 has consistently sought out the best quality Italian made leather jackets at unbelievable prices. Great value for money."
Lot78, Inc. (LOTE), closed Friday's trading session at $1.26, up 3.28%, on 564,662 volume with 306 trades. The average volume for the last 60 days is 54,215 and the stock's 52-week low/high is $0.13/$1.22.
Stellar Biotechnologies, Inc. (SBOTF)
SeriousTraders, FeedBlitz, Streetwise Reports, SmallCapVoice, Vantage Wire, PinnacleDigest, Light Speed Stocks, and Nebula Stocks reported earlier on Stellar Biotechnologies, Inc. (SBOTF), here at the QualityStocks Daily Newsletter.
Stellar Biotechnologies, Inc. is the world leader in sustainable manufacturing of pharmaceutical grade KLH (Keyhole Limpet Hemocyanin). This protein has a highly complex structure that makes it ideal for use in human and animal vaccines as well as diagnostic products. The founding of Stellar Biotechnologies was to address the growing demand for renewable, commercial-scale supplies of high quality, GMP-grade KLH. They've developed leading practices, facilities and proprietary capabilities to address this need. Stellar Biotechnologies has their headquarters in Port Hueneme, California. The Company's shares trade on the OTCQB.
The Company serves the rapidly growing demand for the essential molecule (KLH) in pharmaceutical and diagnostic markets Stellar Biotechnologies ensures supply of the highest quality, GMP-grade KLH protein. They are developing a collection of novel KLH assays and products for immunological use. KLH is an important immunostimulating protein derived only from a limited natural source. Stellar manufactures Stellar KLH™, known for its high purity and immunogenicity.
Stellar has generated important intellectual property (IP). This IP relates to aquaculture technologies, spawning, selection and maintenance of the limited natural source of this pharmaceutical material (Megathura crenulata), as well as processing, purification and engineering of specific stabilized formulations of this protein. KLH is a potent immune-stimulating protein used in a new class of drugs known as conjugate vaccines.
KLH is used as an essential carrier protein in vaccines undergoing development for use in oncology, cardiology (e.g. hypertension), rheumatology (arthritis), neurology (Alzheimer's), and other important clinical indications. Furthermore, KLH is also extensively used as a standard antigen in diagnostic applications including immunotoxicology and assessment of immune status.
This week, Stellar Biotechnologies announced that they submitted a Type IV Biologics Master File (BB-MF) to the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) for the Company's subunit KLH. A Biologics Master File is a confidential, detailed dossier submitted to the FDA. It contains the proprietary information on the manufacture and safety of a drug component. The intention of this new BB-MF is to support Stellar Biotechnologies KLH customers who file applications under the CBER division. This expands applicability of the Company's KLH for more extensive uses.
Stellar Biotechnologies, Inc. (SBOTF), closed Friday's session at $0.631, up 3.83%, on 25,828 volume with 10 trades. The stock's 52-week low/high is $0.191/$0.7035.
Stratus Media Group, Inc. (SMDI)
OTCPicks, Proactivecrg, SmallCapVoice, Outcast Traders, OTCReporter, StockEgg, Penny Invest, Stock Rich, and CoolPennyStocks reported earlier on Stratus Media Group, Inc. (SMDI), PennyTrader, OTC Picks, Stock Traders Chat, OTCReporter, StockEgg, Penny Invest did previously, and we're highlighting the Company today, here at the QualityStocks Daily Newsletter.
Stratus Media Group, Inc. is an owner, operator, developer, producer, and marketer of live entertainment events. Their six entertainment verticals are Motorsports, Action Sports, Film, LUXLife, Music, and Stratus White. Their Stratus White is a new standard in personal lifestyle and card services for the worldwide affluent. Available by invitation only, Stratus White is a discreet, elite member & partner community. They provide exclusive and premier service and access across the luxury product & travel, social, sporting, cultural and philanthropic areas of life, including events and experiences.
Stratus Media Group has their corporate headquarters in Santa Barbara, California. The Company also has offices in Los Angeles, California; New York, New York; Geneva, Switzerland; and Perugia, Italy. Stratus Media's shares trade on the OTC Markets' OTCQB.
The Company's operating strategy is to own 100 percent of the IP (intellectual property rights) of the events they produce. This includes the revenue streams of their properties. These include event entry fees/ticket sales/admissions, participant registration and access fees, corporate sponsorship and advertising packages, VIP membership fees, television/radio/streaming video broadcast rights, licensed event merchandise, hospitality events/functions, and Stratus White Card Member fees/revenue.
Stratus Media presents authentic and lifestyle-driven events across all of their verticals. For example in Film, Stratus Media Group unveiled the Perugia International Film Festival (PIFF) in March of 2012 after successfully launching the PIFF "Preview" in October of 2011 to the global cinema landscape. The Company promotes the art of cinema while emphasizing the importance of film restoration through a unique celebration. They do this with partners such as William Morris Endeavor, Martin Scorsese's The Film Foundation, and the University of Perugia.
Stratus Media Group is targeting acquisitions of event properties. Their corporate goal is to aggressively build-up a critical mass of events, venues and companies that allow for a number of cross-event synergies. The business plan of Stratus is to operate the Stratus White program and to own and realize from their events all available event revenue rights.
Stratus Media Group, Inc. (SMDI), closed Friday at $0.1295, up 7.92%, on 6,100 volume with 3 trades. The average volume for the last 60 days is 37,580 and the stock's 52-week low/high is $0.0751/$0.55.
Viscount Systems, Inc. (VSYS)
The QualityStocks Daily Newsletter would like to spotlight Viscount Systems, Inc. (VSYS). Today, Viscount Systems, Inc. closed trading at $0.089, up 4.22%, on 17,300 volume with 6 trades. The stock’s average daily volume over the past 60 days is 1,485,116, and its 52-week low/high is $0.0069/$0.148.
Viscount Systems, Inc. reported today that the company is all set to file FY12 (ended Dec 31, 2012) financial results with the SEC this coming Wednesday, March 27, and will host a conference call at 4:15pm EDT the same day to go over their successes, as well as the outlook for 2013. Chief among elements highlighted will be the success VSYS has had with the Freedom access control security platform, which did extremely well in what was the first full year of sales for the platform. Contracts with key reference accounts like U.S. DHS, global methanol production giant Methanex, and a major high-rise condo project have generated strong follow-on order headwinds, and it looks like smoothing sailing for VSYS with the business opportunity pipeline for the Freedom platform swelling to around $12M in value.
Viscount Systems, Inc. (VSYS) designs, manufactures, and services access control and security products such as door access control systems and emergency communications systems. The company's products have been installed in approximately 35,000 sites in over 30 countries, including prisons, schools, hospitals, and corporate offices.
Designing security systems since 1969, the company has developed strategic working relationships with leading equipment vendors to support its continued profitability and growth. Viscount has been consistently profitable for nearly 15 years and currently generates annual revenues of approximately $5 million.
Five hundred dealers help distribute Viscount's existing products throughout North America. This distribution network is not static as the company constantly pursues additional sales channels. Products are advertised in various print publications and regularly displayed at tradeshows as well. Direct marketing via training seminars also helps drive sales.
Viscount's management team has more than 60 years of combined experience in the development and production of electronic door control and telecommunication systems. Under this leadership, the SIA Convergence Solution of the Year accolade and Platinum Award for Emergency Response and Gold Award for Access Control at the Government Security Awards (GOVSEC) for 2011 have been presented to the company. Disclaimer
Viscount Systems, Inc. Company Blog
Viscount Systems, Inc. News:
Viscount Systems to Release 2012 Financial Results
Viscount’s Freedom Access Control Technology Secures Dallas High Rises
Viscount Systems To Secure Connecticut School
The Guitammer Company Inc. (GTMM)
The QualityStocks Daily Newsletter would like to spotlight The Guitammer Company Inc. (GTMM). Today, The Guitammer Company Inc. closed trading at $0.15, up 7.14%, on 10,100 volume with 3 trades. The stock’s average daily volume over the past 60 days is 17,188, and its 52-week low/high is $0.082/$0.35.
The Guitammer Company Inc. (GTMM) is a leader in low frequency sound products and technology. Its innovative and award winning line of patented ButtKicker-brand low frequency audio transducers let users feel low-frequency sound (bass). ButtKicker brand products are used around the world by leading entertainment and theater companies such as AMC, IMAX and Disney in movie theaters and attractions; by world-famous musicians; in home theaters, simulators and for car audio.
ButtKicker brand products are distributed by Pearl Drums for musicians under the trade name, "Pearl's Throne Thumper by ButtKicker", and factory installed in home theater seating by Palliser Furniture. ButtKicker brand products' patented design makes them musically accurate, powerful and virtually indestructible. The Company is headquartered in Westerville, OH.
The Guitammer Company's newly patented broadcast technology, ButtKicker LIVE! enables the excitement, impact and feeling of sporting events to be broadcast along with the sound and video. ButtKicker LIVE! puts you into the action, whether you're at home or at the event.
ButtKicker Live! technology is available for cable, satellite, fiber optic, IPTV and over-the-air broadcast and has been successfully tested with several major content (sports) providers. ButtKicker(r) and ButtKicker Live!(r) are registered trademarks of The Guitammer Company. Disclaimer
The Guitammer Company Inc. Company Blog
The Guitammer Company Inc. News:
Lumiere Pavilions Jump Starts Chinese New Year With Eighth Theater Installation of Guitammer's Patented "4D" Technology
The Guitammer Company Announces Strong 2012 Financial Results
Guitammer and State of Ohio Modify Terms of "Innovation Loan"
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.046, up 1.10%, on 35,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 680,544, and its 52-week low/high is $0.001/$0.12.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Reaches Strategic Partnership Agreement With Knockout Gaming
Consorteum Holdings Inc. Reaches Funding Agreement With Private Equity Group
Consorteum Holdings Files Form 10-K Report With the Securities and Exchange Commission
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.087, up 0.12%, on 1,973,001 volume with 97 trades. The stock’s average daily volume over the past 60 days is 4,657,378, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis Nominated for Best Early-Stage Vaccine Biotech at 6th Annual Vaccine Industry Excellence Awards
Advaxis’ ADXS-cHER2 Immunotherapy Researchers Receive Penn One Health Award for Initiatives in Canine Osteosarcoma
Advaxis Provides Business Outlook for 2013
Viscount Systems, a leading-edge supplier of security systems and software, announced today that the company will be filing its financial results for the year ended December 31, 2012, with the SEC on Wednesday of next week.
The company also told investors that it will be hosting a conference call at 4:15pm EDT on the same day to discuss the financial results and provide a corporate update. Shareholders and all interested members of the financial community, including analysts, brokers and interested investors, are all invited to participate.
Stephen Pineau, Chief Executive Officer of Viscount Systems, commented, “We look forward to this call as an opportunity to update our shareholders on the success we’ve had with our Freedom access control security platform. Last year was the first full year of Freedom sales, and we were able to win early stage contracts with important reference accounts, including: in the federal market, the U.S. Department of Homeland Security; in the industrial market, Methanex, the world’s largest producer of Methanol; and in the commercial market, a high-rise condominium project. These deployments helped to demonstrate that Freedom offers enhanced security at a significantly reduced price point when compared to competing systems, and enabled us to close two rounds of financing with our first institutional investors.”
“So far in 2013, we have announced follow-on purchase orders from the U.S. government and new contracts with a diverse set of commercial customers, including two school districts, a Canadian hotel chain and a large, U.S. industrial facility,” he added. “Our pipeline of business opportunities for Freedom is currently valued at more than $12 million, its highest level since the launch of Freedom and a number significantly greater than our pipeline of one year ago. We are working diligently towards converting this potential value into actual sales. We’ve been in active discussions with strategic channel partners in order to accelerate our market presence and reach, and we expect to conclude agreements with one or more of these companies. Finally, we have improved our ability to execute on our growth plan and manage our growth by bringing on a new Chief Operating Officer and additional salespeople.”
For more information on Viscount Systems, visit www.viscount.com
Cardero reported some major deals today related to their Carbon Creek coal deposit, as a non-binding letter of intent has been inked between the company’s Cardero Coal Ltd. subsidiary and major area institution Conifex Timber, which will provide a nine-month exclusivity window for the company to secure a definitive lease agreement and operating agreement for a sizeable new transload facility on a piece of land in the Industrial Zone at Mackenzie, BC.
The plan here is for CDY is to implement a transload facility in support of their flagship Carbon Creek metallurgical coal deposit operations in BC’s Peace River Coal District. This massive, advanced-stage project with current ASTM Coal Rank mvB reserves in excess of 121M tonnes (469M tonnes measured and indicated) has a bright future, and the transload facility would become the main interface for a barge/rail hand-off workflow of material coming out of the mine and headed for the Ridley Terminals facility at Prince Rupert.
In addition, Cardero is reporting having entered talks with wholly-owned Confiex transportation subsidiary and complete end-to-end transportation solutions provider, Navcor Inc., for the transload facility’s operating agreement. The 2012 Prefeasibility Study completed by the company on Carbon Creek was very encouraging and has prompted a bankable feasibility study, due in large part to solid-looking cash flow estimates of around $2.2B (NPV8 of $633M, IRR of 24%, and all on a post-tax, 75% basis). Navcor is the perfect choice really and CDY will be getting considerable bottom-line mileage out of their vast expertise in commodity bulk transport, with Navcor having its hands on both the day-to-day transload facility operations and the CN Rail shipment management between Mackenzie and Ridley.
The transload facility will essentially be the go-between for material hand off, making use of a barge docking system and railcar loading system to get coal onto train tracks and moving towards Ridley. Initial lease on the project will be as much as 20 years (renewable to 40) and given current plans, the new infrastructure will support as much as 5M tonnes a year of throughput. While a formal transload operating agreement has yet to be signed, the LOI framework creates confidence that over the next few weeks, as the company moves to finalize track design and layout requirements with Navcor (for incorporation into the ongoing feasibility study prep work), details of the transload operating agreement will crystallize. Also still pending are settlement and execution of a definitive lease document, as well as other customary lease conditions, like performance of satisfactory due diligence by CDY.
Cardero also needs to nail down the necessary rail service, water lease, and ancillary permitting for the transload facility, but this shouldn’t be much of an issue and the net result will be an extremely cost-effective commodity transit loop. A processing node north of the planned mine will handle loading up clean coal for the roughly 109 mile barge trip to the transload facility in Mackenzie. This is a super cheap way to do all of this compared to just trucking the material and the overall environmental impact will also be reduced sharply, not to mention the lower logistical overhead and safety advantages.
Good call by CDY to lean on the experience of Conifex here and the overall portrait that is shaping up for their feasibility study of the Carbon Creek project just gets better and better looking, with these transload facility dealings marking a high-water point for the process thus far. Officer and shareholder of CDY, the company’s Exec VP, Keith Henderson, PGeo, acted as NI 43-101 qualified person for technical details contained in today’s report and has approved the relevant content herein.
Looks like the required geotechnical testing for the rail track, as well as necessary civil work, is on-schedule for completion this year. Interested parties can take a closer look at the deal, the project, or the company by heading over to the following Web site: www.Cardero.com.
Mr. Hong Zhao is joining SciClone Pharmaceuticals as its new Chief Executive Officer¬–China Operations. An accomplished industry executive, Mr. Zhao has over 20 years in the pharmaceutical industry and has led the commercial operations, market expansion, and growth of several multi-national companies throughout China.
Mr. Zhao joins SciClone from Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals. As the company’s Executive Vice President, his responsibilities included leading a sizeable sales team and managing multiple business units, and had direct reporting responsibility for medical affairs, market access, marketing and sales operations, training, and personnel development.
Prior to Simcere, he held various senior positions at Novartis China, including Regional Sales Manager, National Sales Director, Vice President, Senior Vice President of Novartis Greater China and General Manager of Novartis Shanghai. Mr. Zhao also served with Xi’an Janssen Pharmaceutical, where he rose quickly from Medical Representative to District Sales Manager. Mr. Zhao holds a Bachelor of Medicine degree from Nanjing Medical College and an Executive Masters of Business Administration degree from China European International Business School (CEIBS). He is fluent in Mandarin and in English.
“Hong Zhao is a skilled executive with proven ability to exceed aggressive performance goals, deliver strong top and bottom-line performance, manage and inspire effective sales organizations, establish productive relationships with industry partners and implement innovative and effective corporate strategies,” said Friedhelm Blobel, Ph.D., SciClone’s Chief Executive Officer. “Throughout his career, he has demonstrated the ability to bring new ways of thinking into his companies, implement effective sales force management strategies, incentives and performance measures, align organizations toward growth and leverage the full potential of individuals and teams. SciClone’s board of directors and management team join me in welcoming Hong to our Company. We look forward to working together to lead SciClone to its next level of performance in China.”
“I believe that SciClone has significant potential to enhance its stature and reputation as a growth-focused mid-size pharmaceutical company with a high quality, differentiated marketed product portfolio, led by ZADAXIN®, one of the most respected brands among patients and physicians in China,” added Mr. Zhao. “I look forward to working with Friedhelm and the talented SciClone team to build a consistently top-performing commercial organization, strengthen our focus on ensuring compliance and integrity throughout our operations and continue to deliver value to all of our stakeholders.”
For more information, visit www.sciclone.com
Star Scientific, a technology-oriented company with a mission to promote maintenance of a healthy metabolism and lifestyle, announced that the company’s dietary supplement, Anatabloc®, has been selected as the recipient of the annual GNC Top Vendor Awards. Specifically, Anatabloc® was selected by GNC as the Wellness Winner in the category of Best Product Innovations for 2012. GNC announced the award recipients via its social media outlets and recognized them at the 2014 Arnold Sports Festival in Columbus, Ohio.
GNC selected Anatabloc® as the award recipient based on several criteria, including: success in bringing a product into a mature, competitive category; success in establishing the product with effective marketing, sampling, and trial drivers; and success in becoming a best-selling new product.
“We could not ask for a better partner than GNC,” said David Dean, Vice President of Sales and Marketing for Star Scientific, Inc. “The growth of Anatabloc® and increase in awareness of the product over the past year could not have happened without the support of GNC. We are honored to have been chosen for this award.”
Tom Dowd, Executive Vice President, Chief Merchandising Officer & General Manager of GNC, commented, “Sales of Anatabloc® continue to surpass our expectations. We are proud to recognize Star Scientific and Anatabloc® with the 2012 GNC Top Vendor Award for Best Product Innovation in the Wellness category.”
STSI recently increased the number of lozenges/tablets in both its Anatabloc® and Anatabloc® Unflavored products by 50% of the former quantity, from 200 to 300. This number was altered to reflect a change in usage of the products after researchers for the company developed a new recommended dosage based on body weight. The newly formulated weight classification and usage recommendation chart is now displayed on Anatabloc® packaging and on the Anatabloc® website (www.anatabloc.com). The transition in dosage and increased lozenges per bottle will be complete in all GNC stores during the month of April.
GNC also announced that its Anatabloc® Rare Cellular Facial Creme is now available for sale on the company’s website (www.GNC.com), as well as on the Anatabloc® website (www.anatabloc.com). The company additionally revealed that an Anatabloc® facial cleanser and serum are currently in development.
For more information on Star Scientific, visit www.starscientific.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Nominated for Best Early-Stage Vaccine Biotech at 6th Annual Vaccine Industry Excellence Awards
- Consorteum Holdings, Inc. (CSRH) Reaches Funding Agreement With Private Equity Group
- Cardium Therapeutics, Inc. (CXM) Receives ISO Certification for Excellagen
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- HII Technologies, Inc. (HIIT) Announces Engagement of QualityStocks Investor Relations Services
- International Stem Cell Corp. (ISCO) to Host Conference Call on Friday, March 22 to Discuss Positive Study Data of Parkinson's Disease
- Loans4Less.com, Inc. (LFLS) Engages CPA Firm to Audit Financials
- Rainbow Coral Corp. (RBCC) Forms Joint Venture With Cutting-Edge Drug Delivery Company TheraKine
- Soul and Vibe Interactive Inc. (SOUL) to Pursue Business Development Deals at Game Connection Conference in San Francisco
- The Guitammer Company Inc. (GTMM) Lumiere Pavilions Jump Start Chinese New Year With Eighth Theater Installation of GTMM's Patented "4D" Technology
- VentriPoint Diagnostics Ltd. (VPTDF) Applies for European and Canadian Approvals for A New Application for Non-Specific Heart Disease
- Viaspace, Inc. (VSPC) 25 Acres of Giant King Grass Shipped and Growing in St. Croix
- Viscount Systems, Inc. (VSYS) Freedom Access Control Technology Secures Dallas High Rises
- VistaGen Therapeutics, Inc. (VSTA) to Present Enhancements and Expanded Validation of LiverSafe 3D™ at Society of Toxicology's 52nd Annual Meeting